Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression.

We performed a pilot study in which 22 kidney recipients (14 LD: 8 DCD) were given alemtuzumab induction (30 mg day 0 and 1), steroids (500 mg mp day 0 and 1, none thereafter), mycophenolate mofetil (MMF) maintenance (500 mg b.i.d) and sirolimus (concentration controlled 8-12 ng/mL). With a mean fol...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Flechner, S, Friend, P, Brockmann, J, Ismail, H, Zilvetti, M, Goldfarb, D, Modlin, C, Mastroianni, B, Savas, K, Devaney, A, Simmonds, M, Cook, D
Format:	Journal article
Sprache:	English
Veröffentlicht:	2005

Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression.

Ähnliche Einträge